argenx SE

Healthcare

NASDAQ:ARGX · NASDAQ Global Select

Market Cap $55.29B Beta -0.03 P/E (TTM) 49.3

$893.52 -0.60%

-$5.42 today

52W Low $510.06High $934.62

Vol 0.27M · Avg 0.32M

EPS (TTM)$18.38

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+54.62%

Period High

$929.61

Period Low

$537.92

Latest

$893.52

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Regeneron Pharmaceuticals, Inc.

NASDAQ:REGN

$63.06B

Becton, Dickinson and Company

NYSE:BDX

$52.98B

Cardinal Health, Inc.

NYSE:CAH

$52.43B

Edwards Lifesciences Corporation

NYSE:EW

$49.01B

IDEXX Laboratories, Inc.

NASDAQ:IDXX

$44.24B

Haleon plc

NYSE:HLN

$40.31B

Alnylam Pharmaceuticals, Inc.

NASDAQ:ALNY

$37.76B

Agilent Technologies, Inc.

NYSE:A

$36.67B

Alcon Inc.

NYSE:ALC

$32.58B

Veeva Systems Inc.

NYSE:VEEV

$25.92B

What is the latest ARGX filing?

The latest filing shown is 6-K dated Jun 3, 2026.

How many recent filings does ARGX have?

Intrinsic Alpha currently shows 20 recent filings for ARGX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.